Treatment and/or prevention of nonviral epithelial damage

Details for Australian Patent Application No. 2004218880 (hide)

Owner Epistem Limited

Inventors Brady, Gerard

Agent Davies Collison Cave

Pub. Number AU-A-2004218880

PCT Pub. Number WO2004/080443

Priority 0305835.1 14.03.03 GB; 0305837.7 14.03.03 GB

Filing date 11 March 2004

Wipo publication date 23 September 2004

International Classifications

A61K 031/00

A61K 038/00 Medicinal preparations containing peptides

A61K 045/06 Medicinal preparations containing active ingredients not provided for in groups

A61P 001/00 Drugs for disorders of the alimentary tract or the digestive system

A61P 017/02 Drugs for dermatological disorders

A61P 001/04 Drugs for disorders of the alimentary tract or the digestive system

A61K 031/662 - Phosphorus acids or esters thereof having PC bonds, e.g. foscarnet, trichlorfon

A61P 017/12 Drugs for dermatological disorders

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/080443 Priority application(s): WO2004/080443

15 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004218883-Aplidine for multiple myeloma treatment

2004218879-Methods of radiofluorination of biologically active vectors